GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kala Bio Inc (LTS:0JQ2) » Definitions » Ending Cash Position

Kala Bio (LTS:0JQ2) Ending Cash Position : $54.20 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Kala Bio Ending Cash Position?

Kala Bio's Ending Cash Position for the quarter that ended in Jun. 2024 was $54.20 Mil.

Kala Bio's quarterly Ending Cash Position declined from Dec. 2023 ($50.90 Mil) to Mar. 2024 ($48.48 Mil) but then increased from Mar. 2024 ($48.48 Mil) to Jun. 2024 ($54.20 Mil).

Kala Bio's annual Ending Cash Position declined from Dec. 2021 ($94.88 Mil) to Dec. 2022 ($70.75 Mil) and declined from Dec. 2022 ($70.75 Mil) to Dec. 2023 ($50.90 Mil).

Kala Bio Ending Cash Position Historical Data

The historical data trend for Kala Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kala Bio Ending Cash Position Chart

Kala Bio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 98.03 89.76 94.88 70.75 50.90

Kala Bio Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.26 56.06 50.90 48.48 54.20

Kala Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kala Bio's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=70.745+-19.85
=50.90

Kala Bio's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=48.478+5.719
=54.20

Kala Bio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kala Bio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kala Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kala Bio Inc (LTS:0JQ2) » Definitions » Ending Cash Position
Comparable Companies
AVTX FRES FBRX TCRT EQ PMCB NTRB LSTA TFFP COCP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
KALA:USA 27F0:Germany
Address
1167 Massachusetts Avenue, Arlington, MA, USA, 02476
Website
https://www.kalarx.com
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing innovative therapies for rare and severe eye diseases. KALA's lead product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Kala Bio Headlines

No Headlines